Table 1.
Clinicopathologic characteristics of the worked cases of SGCs
| Clinicopathologic variables | frequency | % | |
|---|---|---|---|
| Patient gender | male | 18 | 40.0 |
| female | 27 | 60.0 | |
| Tumor type | Low-grade MEC | 7 | 15.6 |
| High-grade MEC | 13 | 28.9 | |
| Adenoid cystic carcinoma | 12 | 26.7 | |
| Carcinoma ex pleomorphic adenoma | 8 | 17.8 | |
| Acinic cell carcinoma | 5 | 11.1 | |
| Histologic grade | Low-grade carcinomas | 12 | 26.7 |
| High-grade carcinomas | 33 | 73.3 | |
| Tumor site | parotid salivary gland | 23 | 51.1 |
| Submandibular salivary gland | 12 | 26.7 | |
| Soft and hard palate minor salivary glands | 5 | 11.1 | |
| Sublingual major salivary gland | 4 | 8.9 | |
| Retromolar mucosa | 1 | 2.2 | |
| Tumor size | T1 | 7 | 15.6 |
| T2 | 12 | 26.7 | |
| T3 | 17 | 37.8 | |
| T4 | 9 | 20.0 | |
| Status of nodal involvement | positive nodal involvement | 26 | 57.8 |
| negative nodal involvement | 19 | 42.2 | |
| Distant metastasis | present | 17 | 37.8 |
| absent | 28 | 62.2 | |
| TNM stage | stage I | 7 | 15.6 |
| stage II | 6 | 13.3 | |
| stage III | 13 | 28.9 | |
| stage IV | 19 | 42.2 | |
| Incidence of recurrence | Present | 17 | 37.8 |
| Absent | 28 | 62.2 | |
| Incidence of death | Died | 5 | 11.1 |
| Alive | 40 | 88.9 | |
| CTSK expression | Negative expression | 8 | 17.8 |
| Weak expression | 8 | 17.8 | |
| Moderate expression | 6 | 13.3 | |
| Strong expression | 23 | 51.1 | |
| Total | 45 | 100 | |
Frequency table